We found an increased expression of PRAME in cancer tissues compared to the corresponding normal tissues for the most common cancer types among women worldwide (breast cancer, colorectal cancer, lung cancer) in addition to its well-known upregulation in melanoma (Fig. 1a). Here, PRAME is linked to cancer.